A Glimpse Into The Expert Outlook On Dentsply Sirona Through 4 …

Apr 18, 2024 · Analysts have set 12-month price targets for Dentsply Sirona, revealing an average target of $41.5, a high estimate of $42.00, and a low estimate of $41.00.

CouponFollow Extension

$41
OFF

A Glimpse Into The Expert Outlook On Dentsply Sirona Through 4 …

3 weeks from now

Apr 18, 2024 · Analysts have set 12-month price targets for Dentsply Sirona, revealing an average target of $41.5, a high estimate of $42.00, and a low estimate of $41.00.

businessinsider.com

$23
OFF

Deep Dive Into Dentsply Sirona Stock: Analyst Perspectives (8

3 weeks from now

3 days ago · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $23.0, along with a high estimate of $27.00 and a low estimate …

nasdaq.com

28%
OFF

The Latest Analyst Ratings For Dentsply Sirona - Nasdaq

3 weeks from now

Oct 28, 2024 · Revenue Challenges: Dentsply Sirona's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -4.28%. …

nasdaq.com

$334
OFF

Macro Challenges, Byte Suspension, And Soft Demand Throw A …

3 weeks from now

Nov 7, 2024 · We believe Dentsply Sirona is in fine financial health. At the end of 2023, the firm had $334 million in cash and equivalents with about $1.8 billion in long-term debt.

morningstar.com

$31.43
OFF

Critical Insights From Dentsply Sirona Analyst Ratings: What

3 weeks from now

Aug 20, 2024 · Analysts have set 12-month price targets for Dentsply Sirona, revealing an average target of $31.43, a high estimate of $38.00, and a low estimate of $27.00.

nasdaq.com

$950
OFF

Dentsply Earnings: Soft Demand And Byte Suspension Dampen …

3 weeks from now

Nov 7, 2024 · No-moat Dentsply Sirona’s third-quarter results were in line with our expectations. Total sales of $950 million was roughly flat year over year, and adjusted EPS reflected low …

morningstar.com

5%
OFF

Dentsply Sirona Inc (XRAY) Q3 2024 Earnings Call Highlights: …

3 weeks from now

Nov 8, 2024 · Full Year 2024 Outlook - Net Sales: Expected to be in the range of $3.79 billion to $3.82 billion. Full Year 2024 Outlook - Adjusted EBITDA Margin: Approximately 17.5%.

yahoo.com

$334
OFF

Challenging Market Environment In North America And Europe …

3 weeks from now

May 3, 2024 · We believe Dentsply Sirona is in fine financial health. At the end of 2023, the firm had $334 million in cash and equivalents with about $1.8 billion in long-term debt.

morningstar.com

FAQs about A Glimpse Into The Expert Outlook On Dentsply Sirona Through 4 … Coupon?

What are the financial results of Dentsply Sirona?

Charlotte, N.C., February 28, 2023 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its financial results for the fourth quarter and full year 2022. Full year 2022 net sales of $3,922 million decreased (7.3%), compared to $4,231 million for the full year of 2021. ...

What does Dentsply Sirona think about acquisition opportunities?

Dentsply Sirona believes that the dental consumable and technology products industries continue to experience consolidation with respect to both product manufacturing and distribution, thereby creating numerous acquisition opportunities. ...

How does Dentsply Sirona improve organizational efficiency?

Dentsply Sirona is taking significant measures to enhance organizational efficiency by simplifying the business. These initiatives will improve the Company’s efficiency and better leverage its selling, general and administrative infrastructure. ...

How did Dentsply Sirona perform in Q4?

• Q4 net sales decreased (10.9%) to $983 million, organic sales decreased (2.6%) Charlotte, N.C., February 28, 2023 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its financial results for the fourth quarter and full year 2022. ...

Does Dentsply Sirona have a restructuring plan?

Dentsply Sirona developed a comprehensive restructuring plan during late 2018 designed to accelerate growth, improve margins, and simplify the company. Accelerating growth is essential and there were many steps taken to deliver against this priority. ...

What if Dentsply Sirona did not obtain a patent?

See Note 10, Goodwill and Intangible Assets, in the Notes to Consolidated Financial Statements in Part IV, Item 8, of this Form 10-K. Failure to obtain issued patents and protect Dentsply Sirona’s proprietary technology could hurt Dentsply Sirona’s competitive position. ...